4-oxo-1,4-dihydroquinoline M1 receptor positive allosteric modulators

Details for Australian Patent Application No. 2009241392 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Shipe, William D.; Di Marco, Christina Ng; Kuduk, Scott D.

Agent Spruson & Ferguson

Pub. Number AU-A-2009241392

PCT Pub. Number WO2009/134668

Priority 61/126,085 01.05.08 US

Filing date 23 April 2009

Wipo publication date 5 November 2009

International Classifications

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/134668 Priority application(s): WO2009/134668

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241396-Generation of a computerized bone model representative of a predegenerated state and useable in the design and manufacture of arthroplasty devices

2009241388-Small aperture interrogator antenna system employing sum-difference azimuth discrimination techniques